CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.

Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...

Dr. Jonathan R. Strosberg, discussed results of the CABINET trial evaluating Cabometyx versus placebo in advanced ...

Topline results from the COMPETE trial showed that ITM-11 met the study’s primary end point of PFS in inoperable, progressive ...

After a second breast cancer diagnosis at 61, I faced 17 rounds of chemo, surgery and radiation, changing my perspective on life and leading to a new normal.

A Breakdown of Trial Data that Led to the Subcutaneous Opdivo FDA Approval ...

A Breakdown of Trial Data that Led to the Subcutaneous Opdivo FDA Approval ...

A Breakdown of Trial Data that Led to the Subcutaneous Opdivo FDA Approval ...

A Breakdown of Trial Data that Led to the Subcutaneous Opdivo FDA Approval ...

A phase 3 trial is evaluating ASP-1929 photoimmunotherapy plus Keytruda in first-line treatment for recurrent head and neck ...

BCG therapy is associated with a high frequency of side effects in NMIBC; however, when used in sequential combination with ...

Hope is crucial for those of us with chronic lymphocytic leukemia, or any cancer, helping us navigate the disease's ...